Methodology for the performance of synergistic antibiotic susceptibility studies has not been standardized. Combination antimicrobial therapy is often the rule rather than the exception for the treatment of many infections before the isolation and susceptibility evaluation of the etiological agent(s) (9). Combination therapy should prevent the development of resistance, increase bactericidal activity and, thus, improve therapeutic efficiency, especially in granulocytopenic patients, and provide broad-spectrum activity against bacterial components in polymicrobic infections (11).
concentrations that reflected the breakpoints for each drug; the same ratios of IP-lactam to amdinocillin were used in doubling dilutions with the microdilution method. Initially, each participant studied the same 50 members of the family Enterobacteriaceae; each bacterium was studied on three occasions. Thereafter, 500 representatives of Enterobacteriaceae isolated recently from clinical specimens were studied. Designated strains served as controls. Reproducibility between the two approaches studied in phase 1 of the investigation indicated good agreement between the methods, ranging from 87 to 100%. Agreement between the microdilution and broth-disk tests for the 2,551 clinical isolates ranged from 86 to 95%, with slightly better correlations between combination results than with the single agents. The findings indicate that antibiotic disks used routinely in the clinical laboratory can be used in a simple elution test to determine susceptibility of organisms to jm-lactam antibiotics alone and in combination with amdinocillin.
Combination antimicrobial therapy is often the rule rather than the exception for the treatment of many infections before the isolation and susceptibility evaluation of the etiological agent(s) (9) . Combination therapy should prevent the development of resistance, increase bactericidal activity and, thus, improve therapeutic efficiency, especially in granulocytopenic patients, and provide broad-spectrum activity against bacterial components in polymicrobic infections (11) .
Amdinocillin, an amidino-P-lactam which preferentially binds to penicillin-binding protein 2, differs from acylamino-P-lactams which bind preferentially to penicillin-binding protein 1 or 3 or both. Combinations of amdinocillin and other P-lactams may produce enhanced activity against gram-negative bacteria (4, (12) (13) (14) (15) as a result of dual or sequential inhibition of peptidoglycan synthesis (15) . However, the ability of laboratories to predict synergy between amdinocillin and other ,-lactam agents is subject to the same basic diffiçulties found with other antimicrobial combinations, i.e., different in vitro methods may yield different results, and a correlation between synergy observed in the laboratory and effective therapy of patients has not been established (11) . In addition, since the in vitro activity of amdinocillin is greatly affected by factors such as the size of the inoculum and the ion content, osmolarity, pH, and conductivity of the test medium, reliable measurement of synergistic or additive interactions of amdinocillin and other ,-lactams is even more difficult (3, 4) . Some understanding of amdinocillin-p3-lactam combinations was gained with ani-* Corresponding author. mal studies. Mice were infected experimentally with bacteria of various susceptibilities to each antibiotic and treated with select single P-lactams, amdinocillin, and combinations of the latter with each of the former. Results of therapeutic efficiency were related to the laboratory guidance provided (6) . The objectives of the present study, based on the experience with anaerobic bacteria (17) , were the demonstration of reproducibility of combination microdilution tests, the demonstration that combination disk elution tests are reproducible, and the demonstration of comparability between the combination microdilution and the combination disk elution tests. Broth microdilution test. Each investigator received dehydrated microdilution trays (BBL; Sceptor) containing doubling dilutions of amdinocillin and the other ,-lactams, singly and in combination at the ratios shown in Table 2 . The breakpoints used to interpret susceptibility to the combinations (Table 2) were based on NCCLS guidelines (16) for indicating moderate susceptibility to the various ,B-lactam agents. The same criteria were used for the single agents. For amdinocillin, 8 Fxg/ml was considered to indicate moderate susceptibility (2) .
MATERIALS AND METHODS

Bacteria
The bacterial inoculum was prepared as described above for the broth-disk test. A 10-pi sample was transferred to 10 ml of cation-supplemented MHB and decanted into sterile Sceptor inoculum trays. A multichanneled inoculator (BBL) was used to transfer 100 pi to each well in the tray. After 16 to 18 h of incubation at 35C, the presence or absence of growth was determined using the BBL viewing mirror.
Ratios of amdinocillin to other 13-lactams. For combination testing by microdilution assay, the ratios of amdinocillin to the other P-lactams were based on the levels in serum observed at 0 or 2 h after administration of standard dosages of each drug to volunteers. The ratios used were the same as those used in an earlier study (4) Inc., McLean, Va.) by personnel at Hoffmann-La Roche Inc. The MICs obtained using the Sceptor system and the Dynatech panels were comparable, and for the single ,Blactams they fell within the ranges provided by the NCCLS for reference organisms Streptococcus (Enterococcus) faecalis ATCC 29212 and E. coli ATCC 25922.
Correlation of microdilution and broth-disk susceptibility test results. (i) Results with 50 strains used for inter-and intralaboratory reproducibility studies. The correlations between the reference microdilution assay and the broth-disk tests obtained with the 50 strains ofEnterobacteriaceae used in the microdilution reproducibility studies are shown in Table 6 . These results indicate the degree of agreement that was achieved between the two methods (85 to 100%). In the broth-disk test, inhibition of growth or a faint haze (1+) was considered to indicate susceptibility. This criterion for evaluation was based on results obtained when one of the investigators subcultured all negative and 1 + tubes in 0.1-ml aliquots on Trypticase soy agar plates (BBL) and incubated the plates for 48 h. Only one to two colonies were encountered in less than 20 of such subcultures, which corresponded to 10 to 20 CFU/ml and was within the 99.9% lethal effect of the particular drug or its combination with amdinocillin.
(ài) Results with 2,551 strains of Enterobacteriaceae used in multicenter trial. The correlation obtained between the microdilution method and the broth-disk test with 2,551 strains of Enterobacteriaceae is shown in extremely difficult to correlate the synergy seen in the laboratory with clinical success (1, 9, 11, 14) . A simple test procedure with potential application to the clinical situation, the broth-disk assay (17) , was evaluated in this study to determine the susceptibility of strains of Enterobacteriaceae to amdinocillin-,B-lactam combinations regardless of whether the susceptibility was due to synergy, an additive effect, or intrinsic susceptibility to one or both of the antibacterial agents.
The results of this study clearly show that the broth-disk procedure can be used to qualitatively determine the susceptibility of an organism to combinations of amdinocillin and another ,B-lactam as well as to the individual agents. In addition, this type of assay offers the advantage of allowing laboratories using the disk diffusion assays to determine susceptibility to such combinations or single agents without inconvenient departures from established procedures.
The qualitative nature of the test has been rectified in part by using a volume of broth (2 ml) such that the concentration of the antimicrobial agent eluted from the disk is in the range recommended by the NCCLS for moderate susceptibility. The inter-and intralaboratory variations observed using the reference microdilution method were well within those reported in other studies, indicating that the microdilution assay was reliable as the reference method. When the results of the two tests were compared, agreement between the two approaches in terms of bacterial susceptibility or resistance ranged from 85 to 95% for the 2,551 clinical isolates tested. This degree of agreement is very close to that achieved when comparing dilution and diffusion methods or different dilution modalities with single agents. The broth-disk test appears to be a more conservative predictor of susceptibility than the reference microdilution method, since the percentage of falsely resistant bacteria was considerably higher than that of falsely susceptible ones.
One obvious advantage of this type of approach is the ability to determine the enhancing activity of amdinocillin on other P-lactams in terms of susceptiblity to the combination rather than by attempting to determine synergistic activity which clinically cannot be ascertained.
The results of this extensive study are 
